Skip to content

Omnicell OMCL Deferred Tax Assets

Deferred Tax Assets at other companies

Guardian Pharmacy Services logo
Guardian Pharmacy ServicesGRDN
$2.2M-58.3%
Cencora logo
CencoraCOR
$192.83M-17.5%
ICU Medical logo
ICU MedicalICUI
$25.65M+5.8%
Haemonetics logo
HaemoneticsHAE
$9.52M+22.0%
Solventum logo
SolventumSOLV
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.75B-7.2%
Enterprise value$1.49B-0.4%
P/E113.2×
P/S1.4×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's deferred tax assets?
Omnicell (OMCL) reported deferred tax assets of $54.06M in Q1 2026.
How has Omnicell's deferred tax assets changed year-over-year?
Omnicell's deferred tax assets decreased by 11.9% year-over-year, from $61.36M to $54.06M.
What is the long-term trend for Omnicell's deferred tax assets?
Over 5 years (2020 to 2025), Omnicell's deferred tax assets has grown at a 31.2% compound annual growth rate (CAGR), from $15.02M to $58.34M.
What does deferred tax assets mean?
Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.